Which screening strategy should be offered to women with BRCA1 or BRCA2 mutations? A simulation of comparative cost-effectiveness

BACKGROUND: There is no consensus on the most effective strategy (mammography or magnetic resonance imaging (MRI)) for screening women with BRCA1 or BRCA2 mutations. The effectiveness and cost-effectiveness of the Dutch, UK and US screening strategies, which involve mammography and MRI at different...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: de Bock, G H, Vermeulen, K M, Jansen, L, Oosterwijk, J C, Siesling, S, Dorrius, M D, Feenstra, T, Houssami, N, Greuter, M J W
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2013
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3668482/
https://ncbi.nlm.nih.gov/pubmed/23579217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2013.149
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados